Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain
AssigneeJohnson Matthey Public Limited Company
InventorRobert S. Marmor
Life of this patent
Estimating the term…
Loading patent…
AssigneeJohnson Matthey Public Limited Company
InventorRobert S. Marmor
Estimating the term…
Processes for reducing the amount of impurities, especially α,β-unsaturated ketones (ABUK), in materials containing morphine. Novel compounds, namely low ABUK morphine sulfate methanolic solvate, and a novel crystal form are also described. The method for making morphine sulfate methanolic solvate comprises mixing a morphine free base composition with methanol to form a solution and adding a liquid comprising sulfuric acid to the solution to form a morphine sulfate methanolic solvate precipitate. A method of making a morphine sulfate compound comprises drying the morphine sulfate methanolic solvate in the presence of water vapor, such that methanol molecules are removed and replaced with water vapor molecules. A composition for treating pain comprises the morphine sulfate compound and at least one pharmaceutically acceptable excipient. A method for treating pain comprises administering to a patient in need thereof the composition comprising the morphine sulfate compound and at least one pharmaceutically acceptable excipient.
A method of making a morphine sulfate methanolic solvate composition comprising:
A method of making a morphine sulfate methanolic solvate composition comprising:
Crystalline morphine sulfate methanolic solvate containing less than 25 ppm of α,β-unsaturated ketones.
Crystalline morphine sulfate methanolic solvate exhibiting an x-ray powder diffraction pattern substantially as shown in FIG. 4.
Crystalline morphine sulfate methanolic solvate exhibiting an x-ray powder diffraction pattern having at least one peak in degrees 2θ selected from 9.3, 9.6, 10.7, 13.5, 14.3, 16.4, and 23.5.
Crystalline morphine sulfate methanolic solvate exhibiting a differential scanning calorimetry curve substantially as shown in FIG. 5.
Crystalline morphine sulfate methanolic solvate having an onset of melt temperature of about 137° C. by differential scanning calorimetry.
Crystalline morphine sulfate methanolic solvate having a melting point temperature of about 143° C. by differential scanning calorimetry.
A method of making a morphine sulfate compound comprising:
A morphine sulfate compound comprising a crystalline morphine product containing water and methanol molecules and containing less than 0.15% by weight methanol.
Dependencies are inferred from the claim text.